Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06280664 · ClinicalTrials.gov registry record
Efficacy Of Hiatal Closure For GERD
A clinical trial of Gastroesophageal Reflux, sponsored by University of Chicago.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06280664: Recruiting study of Gastroesophageal Reflux, sponsored by University of Chicago.
NCT06280664 is a study of Gastroesophageal Reflux that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 40 participants, below the 2,885-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06280664, a study of Gastroesophageal Reflux, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.
Primary Outcome
Determine GERD remission for hiatal closure alone for patients with pH proven GERD
Conditions Studied
Study Locations (1)
Illinois
- The University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-10-02 |
| Est. Completion | 2028-10 |
What NCT06280664 shows while recruiting
NCT06280664 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 2,885-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 0 interventions.
NCT06280664 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06280664 about?
NCT06280664 is a clinical study titled "Efficacy Of Hiatal Closure For GERD". The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.
What is the current status of trial NCT06280664?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2020-10-02. Estimated completion is 2028-10.
What conditions does trial NCT06280664 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux.
Who is sponsoring clinical trial NCT06280664?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06280664 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06280664's enrollment target sits among peer trials
40 27th of 33 higher than 6 of 33 other Gastroesophageal Reflux trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroesophageal Reflux trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
RECRUITING · NA
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Barrett's Esophagus Related Neoplasia (BERN) Project
RECRUITING
-
External UES Band (Shaker Pressure Band) and GERD
RECRUITING · NA
-
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI